Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany Cuts Pharma Rebate Level While Keeping Price Freeze

This article was originally published in The Pink Sheet Daily

Executive Summary

German coalition negotiation proposals will see government slash the obligatory rebate for pharma companies while continuing the current prize freeze. But old products will be exempt from HTA.


Related Content

No Thaw In Sight: German Bill Extends Price Freeze To 2022
German Drug Price Freeze Confirmed For Four Years In Latest Reforms
Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts
German Pharma Balks As Second HTA Retrospective Assessment Includes Orphan Drugs
Germany's Health Reform Law Stumbles Through Parliament


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts